| Revenue | NOK 0 | — |
| EBITDA | NOK -886K | -4% |
| Net profit | NOK -887K | -4% |
| Total assets | NOK 64K | +95% |
| Equity | NOK 49K | +501% |
| Employees | 0 | — |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 11 | 3 | 3 | 0 | 0 | 0 | 0 |
| Staff expenses | −8 | −8 | −5 | −10 | −23 | −18 | −18 |
| EBITDA | −406 | −674 | −643 | −727 | −752 | −853 | −886 |
| Depreciation & amort. | −51 | −67 | −24 | −24 | −24 | −0 | −0 |
| EBIT | −456 | −740 | −667 | −751 | −776 | −853 | −886 |
| Net financials | −1 | −0 | −0 | −0 | −1 | −0 | −0 |
| Profit before tax | −457 | −741 | −667 | −751 | −777 | −853 | −887 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −457 | −741 | −667 | −751 | −777 | −853 | −887 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 161 | 148 | 173 | 111 | 66 | 33 | 64 |
| Equity | 135 | 147 | 158 | 90 | 42 | −12 | 49 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 26 | 1 | 16 | 21 | 23 | 45 | 15 |
| Total debt | 26 | 1 | 16 | 21 | 23 | 45 | 15 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AD Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
SE Chief Executive Officer | Chief Executive Officer | 2012 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
DELUCA EYE AS | Company | 0.0% | 0.0% | 2025 |
KVINNELEGEN I HEDMARK AS | Company | 0.0% | 0.0% | 2025 |
HEDMARK HUDLEGESENTER AS | Company | 0.0% | 0.0% | 2020 |
KVINNELEGEN I HEDMARK INVEST AS | Company | 0.0% | 0.0% | 2020 |
ELVERUM ØYEKLINIKK AS | Company | 0.0% | 0.0% | 2020 |
| Person | Role here | Other companies |
|---|---|---|
| Anthony De Luca | Chief Executive Officer | 0 companies |
| Signe Eriksen | Chief Executive Officer | 0 companies |